This study was designed to determine whether intermittent warm aortic crossclamping induces cumulative myocardial stunning or if the myocardium becomes preconditioned after the first episode of ischemia in canine models in vivo. The role of adenosine triphosphate catabolism and subsequent release of purines on reperfusion-mediated postischemic ventricular dysfunction and arrhythmias was assessed with the use of selective inhibitors of nucleoside transport, p-nitrobenzylthioinosine (NBMPR), and a specific adenosine deaminase inhibitor, erythro-9-[2-hydroxy-3-nonyl] adenine (EHNA). Thirty-two anesthetized dogs were instrumented to monitor left ventricular contractility, off bypass, by sonomicrometry. During cardiopulmonary bypass dogs were treated before ischemia with either saline solution (control group, n = 8) or EHNA (100 pmol/L) and NBMPR (25/~mol/L) (EHNA/NBMPR group, n = 8). Hearts were subjected to either 60 minutes of global ischemia and 120 minutes of reperfusion (n = 16) or 6 episodes of 10 minutes of global ischemia and 10 minutes of reperfusion, followed by 60 minutes of reperfusion (n = 16). Sixty minutes of sustained ischemia resulted in 80% loss of adenosine triphosphate and induced reperfusion-mediated ventricular fibrillation and severe left ventricular dysfunction in the control group. EHNA/NBMPR treatment augmented myocardial adenosine trapping during ischemia, attenuated ventricular fibrillation, and enhanced left ventricular functional recovery, despite similar depletion of adenosine triphosphate (80% loss). In the intermittent ischemia experiment, the first episode of 10 minutes of ischemia and reperfusion caused significant adenosine triphosphate depletion, ventricular fibrillation, and left ventricular stunning in both control and drugtreated groups. The prevalence of ventricular fibrillation was greater in the control group than in the drug-treated group after the first episode of ischemia (p < 0.05). Adenosine was the major nucleoside accumulated in the myocardium at the end of 10 minutes of ischemia in the EHNA/ NBMPR-treated group (p < 0.05 versus control). Subsequent episodes of ischemia prevented ventricular fibrillation and did not cause cumulative left ventricular stunning in either group. Left ventricular function fully recovered in the EHNA/NBMPR-treated group after intermittent ischemia, but remained stunned in the control group. Unlike sustained ischemia, intermittent ischemia and reperfusion preserved myocardial adenosine triphosphate, limited purine release, and prevented ventricular fibrillation and cumulative stunning. These results suggest that intermittent ischemia and reperfusion augmented the endogenous protective
mechanism or mechanisms of "preconditioning." Nucleoside trapping improved functional recovery after sustained or repetitive ischemia. It is concluded that adenosine triphosphate preservation or blockade of nucleoside transport may play an important role in the activation of endogenous myocardial protective mechanisms that "precondition" against subsequent ischemic stress. (J TnORAC CARDIO-VASC SURG 1995;110:328- 39) A lthough hypothermic cardioplegic arrest has been the procedure of choice for myocardial protection during coronary artery bypass grafting, some surgeons continue to use an old technique of intermittent noncardioptegic warm aortic crossclamping with satisfactory results, and interest in this technique has been renewed. Mechanisms underlying myocardial injury during warm intermittent global ischemia and reperfusion are not known. [1] [2] [3] Recently, intermittent warm cardioplegic arrest has been used as a mean of myocardial protection during elective cardiac operation. 1 A brief coronary artery occlusion provokes depletion of adenosine triphosphate (ATP), reperfusionmediated ventricular fibrillation, and persistent ventricular dysfunction referred to as myocardial stunning. [4] [5] [6] [7] [8] On the other hand, repetitive brief coronary artery occlusion and reperfusion have been shown to significantly reduce the rate of ATP depletion and concomitant accumulation of ATP catabolites 9, lo and to limit the infarct size after a sublethal period of sustained ischemia and reperfusion. ~1 A single episode of 5 minutes of coronary artery occlusion produced a similar antiinfarction response. ~2 These observations suggested that the myocardium becomes more tolerant to ischemia by activating an adaptive response to short periods of ischemic stress. The reduction of the infarct size after brief ischemia and reperfusion followed by prolonged ischemia and reperfusion has been referred to as ischemic preconditioning. 1~' 12 It is not known whether a brief episode of ischemia and reperfusion also limits ventricular dysfunction after intermittent ischemia and reperfusion in a canine model of warm aortic crossclamping.
The mechanisms of myocardial stunning and ischemic preconditioning have not been fully elucidated because of age-, species-, and model-related differences. 13 Oxygen-derived free radicals 8'14 and impairment of contractile apparatus and handling of calcium by sarcoplasmic reticulum ~s have been implicated in myocardial stunning. Preservation of myocardial ATP, 11 activation of A 1 receptors, 12 and ATP-sensitive potassium channels a6 and induction of heat-shock proteins 17 are among potential mechanisms of cardioprotection associated with ischemic preconditioning. Pharmacologic trapping of endogenous adenosine by a selective nucleoside transport blocker, p-nitrobenzylthioinosine (NBMPR), and a specific adenosine deaminase inhibitor, erythro-9-[hydroxy-3-nonyl]adenine (EHNA), has been shown to attenuate ventricular dysfunction after 30 and 60 minutes of ischemia in dogs 18-21 without a prior ischemic preconditioning episode. It is not known whether entrapment of endogenous adenine nucleoside augments ventricular functional recovery and attenuates ventricular arrhythmias during intermittent aortic crossclamping and reperfusion.
In the clinical setting, myocardial stunning and ischemic preconditioning may occur during repeated angina, angioplasty, or thrombolysis. [22] [23] [24] Whether the phenomena of myocardial stunning and preconditioning occur during cardiac operation with noncardioplegic warm intermittent aortic crossclamping is not known. The role of ATP depletion and nucleoside accumulation and release during intermittent ischemia and reperfusion was investigated in the present studies.
Material and methods
The following study protocols conform with the guiding principles of the American Physiological Society. All animals were treated humanely in accordance with the United States Public Health Service Standards as outlined in "Principles of Laboratory Animal Care" formulated by the National Society of Medical Research and the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health.
Material. Biochemical reagents were obtained from Sigma Chemical Company (St. Louis, Mo.). NBMPR was obtained from Aldrich Chemical Company (Milwaukee, Wis.); EHNA was purchased from Sigma Chemical Compaw.
Animal preparation. Thirty-two microfilaria-free dogs of either sex, weighing 19 to 26 kg, were anesthetized with intravenous injections of sodium pentobarbital (Nembu-tal, 30 mg/kg, Abbott Laboratories, Chicago, Ill.). Dogs were intubated and the lungs mechanically ventilated with a Bennett MA1 respirator (Puritan, Berkeley, Calif.). The azygos vein was ligated and the right phrenic nerve was transected to eliminate diaphragmatic contractions. The sinoatrial node was crushed, and the heart was paced at 150 beats/rain with a Medtronie 5880A pacemaker (Medtronic, Inc., Minneapolis, Minn.). Porcine-based heparin (400 units/kg, given intravenously) was injected before bypass followed by 200 units/kg per hour (Elkins-Sinn Inc., Cherry Hill, N.J.). Cardiopulmonary bypass was initiated by subclavian artery cannulation for blood inflow and right atrial cannulation with use of a double-stage cannula for venous drainage. A bubble oxygenator (Cobe CML50, 100, Cobe, Lakewood, Colo.) primed with noncrossmatched homologous blood was used. Arterial blood gas values, pH, hematocrit, and electrolyte levels were determined before and during bypass. Mean arterial perfusion pressure was maintained at 65 mm Hg during cardiopulmonary bypass.
Assessment of left ventricular performance and reperfusion-mediated arrhythmias. Intraventricular and carotid artery micromanometer-tipped catheters (Millar Instruments, Inc., Houston, Tex.) were used to monitor left ventricular and systemic pressure, respectively. LV dimensions were obtained with pulse transit sonomicrometry (Triton Technology, San Diego, Calif.). One pair of 2.5 mm diameter LTZ-piezoelectric hemispheric crystals (Channel Industries, Santa Barbara, Calif.) was sewn onto the anterior and posterior myocardial wall along the minor axis of the left ventricle. The epicardial diameter of the left ventricle ranged from 40 to 66 ram. Analog data were digitized at 200 Hz and stored on the hard disk of a PC 386 microcomputer. Subsequent analysis was done with the use of interactive software Crunch program developed in our laboratory. To assess left ventricular performance, the dog was first temporarily weaned from bypass. Then the left ventricular and arterial pressures were elevated to 100 to 120 mm Hg by crossclamping the venous drainage and increasing the blood inflow through the subclavian eannula by the roller pump. The relationship of stroke work/end-diastolic length was established over a range of end-diastolic volumes produced by emptying venous blood into the cardiopulmonary bypass reservoir during 25 to 50 beats (10 to 20 seconds). Cardiopulmonary bypass was then reestablished. During data collection, all hemodynamic parameters changed, corresponding to the left ventriclar emptying maneuver, except the heart rate, which was kept constant by electric pacing (150 beats/rain). Work loops were produced on a screen and recorded, and the relationship between stroke work and end-diastolic length was calculated using Crunch program analysis. The slope of this linear relationship is the most sensitive index of contractility, independent of the load within the physiologic rangeY' 26 Assessment of left ventricular function by this method is more accurate than hemodynamic and load-dependent indices of contractility such as left ventricular arterial pressure and positive and negative values of the rate of left ventricular pressure rise. The latter parameters decreased as the work loop diminished during data collection because of varying preload. The numbers of occurrences of ventricular fibril-lation and successful resuscitation were recorded and the frequency of reperfusion-mediated ventricular tachycardia was determined during lO-minute periods of intermittent or sustained reperfusion.
Assessment of adenine nucleotide pool intermediate metabolism. In a random fashion, transmural Tru-Cut needle (Travenol Laboratories, Inc., Deerfield, Ill.) biopsy specimens (5 to 10 rag) were obtained during 60 minutes of intermittent normothermic global ischemia and 60 minutes of sustained reperfusion. Biopsy samples were immediately frozen and stored in liquid nitrogen. Purines in each biopsy specimen were extracted with 12% trichloroacetic acid (4°C) and neutralized. Denatured protein content from each biopsy specimen was determined as previously described by Lowry. 27 Levels of myocardial ATP, adenosine diphosphate (ADP), adenosine monophosphate (AMP), adenosine, inosine, hypoxanthine, xanthine, and the oxidized form of nicotinamide-adenine dinucleotide were determined with high-performance liquid chromatography and expressed as nanomoles per milligram protein. 28" 29 Experimental protocol. Dogs underwent either 60 minutes of sustained myocardial ischemia and 120 minutes of rcperfusion or six episodes of 10 minutes of normothermic global myocardial ischemia and 10 minutes of reperfusion, followed by 60 minutes of continuous perfusion during cardiopulmonary bypass. All hearts underwent 60 minutes of global warm ischemia and 120 minutes of reperfusion.
To determine the role of purine release on ventricular dysfunction, arrhythmias, and adenine nucleotide pool metabolism, a selective nucleoside transport blocker, NBMPR, and an adenosine deaminasc inhibitor, EHNA, were infused into the bypass reservoir before ischemia. One bolus (500 ml) of either saline solution (in the control group) or a solution of EHNA (100/xmol/L) and NBMPR (25 txmol/L) (in the EHNA/NBMPR-trcated group) was infused into the pump reservoir before ischemia. The effects of the vehicle or drugs on left ventricular contractility and the levels of myocardial adenine nucleotide and nucleoside metabolism were determined in normal hearts before ischemia. A second bolus (500 ml) was infused immediately before sustained ischemia or before the first episode of ischemia. A third bolus (500 ml) was infused at the beginning of 60 minutes of sustained reperfusion to ensure availability of effective inhibitor concentrations.
Transmural biopsy specimens were obtained before ischemia, at the end of each episode of ischemia and reperfusion, and during sustained reperfusion. Left ventricular performance was assessed, after the dog was weaned from bypass, from the slope of the relationship between stroke work and end-diastolic length. Postischemic reperfusion-mediated ventricular arrhythmias were documented after each ischemic episode.
Statistical analysis. Data are presented as mean plus or minus the standard error of the mean. Sequential measurements were compared with repeated-measures analysis of variance (ANOVA) with SAS software (Statistical Analysis System Institute, Cary, N.C.). Subsequent comparisons were made between groups at each individual period of the experiment by the method of Newman and Keuls. Differences were considered significant if the Abd-EIfattah, Ding, Wechsler 3 3 1 Fig. 1 . Effect of sustained global ischemia on ATP metabolism and ventricular performance with and without nucleoside trapping. Effect of sustained warm ischemia (60 minutes) on ATP, adenosine inosine levels, and ventricular performance in presence and absence of EHNA/NBMPR. A, Effect of sustained ischemia on ATP. Levels of ATP were determined before, during, and after 60 minutes of ischemia (37 ° C). There were statistically significant differences between groups (p < 0.05, ANOVA, n = 8 each group).
Significant differences between groups at each point are represented by asterisks. B, Effect of sustained ischemia on adenosine. Adenosine levels were determined before, during, and after 60 minutes of ischemia (37 ° C). There were statistically significant differences between groups (p < 0.05, ANOVA, n = 8 each group). Significant differences between groups at each point are represented by asterisks. C, Effect of sustained ischemia on inosine. Inosine levels were determined before, during, and after 60 minutes of ischemia (37 ° C). There were statistically significant differences between groups (p < 0.05, ANOVA, n = 8 each group). Significant differences between groups at each point are represented by asterisks. D, Effect of sustained ischemia on left ventricular performance. Left ventricular performance was determined before and after vehicle of EHNA/NBMPR administration to determine the effect of drugs on normal myocardial function. There were no significant differences between groups before ischemia. Significant recovery of ventricular function after 60 minutes of sustained ischemia was observed in EHNA/NBMPR-treated group, whereas recovery was severely impaired in control group (p < 0.05, ANOVA, n = 8 each group). significant differences between groups at each point are represented by asterisks. CPBP, Cardiopulmonary bypass; G × T, group and time; SW/EDL, stroke work/end-diastolic length.
probability value (p) for comparison of best least-squares means was less than 0.05.
Results
Sustained ischemia. Sixty minutes of sustained ischemia caused severe depletion of myocardial ATP (about 80% loss) ( Fig. 1,A) and concomitant accumulation of nucleosides ( Fig. 1, B and C) in the control ,and EHNA/NBMPR-treated groups.
Frequency of reperfusion-mediated ventricular fibrillation was greater (100%) in the control group than in the drug-treated group (68%) after 60 minutes of sustained ischemia (p < 0.05). Left ventricular function was completely recovered in the EHNA/NBMPR-treated group, whereas poor recovery of function (23% of baseline value) was observed in the control group (Fig. 1, D) Fig. 2 . Effect of intermittent ischemia on ATP with and without nucleoside trapping. Effect of intermittent global normothermic ischemia and reperfusion on myocardial ATP in presence and absence of EHNA/ NBMPR is depicted. There were no significant differences between groups with respect to ATP levels as demonstrated by ANOVA (p = NS, n = 8 each group). However, at one point only there was significant increase in ATP between groups, as represented by asterisk. Fig. 3 . Effect of intermittent ischemia on ventricular performance with and without nucleoside trapping. Effect of intermittent global normothermic ischemia and reperfusion on left ventricular function in presence and absence of EHNA/NBMPR is depicted. There were significant differences between groups after reperfusion (p < 0.05, ANOVA, n = 8 each group). Significant differences between groups at each point are represented by asterisks.
Intermittent ischemia. Fig. 2 depicts the effect of intermittent normothermic global ischemia and reperfusion on ATP depletion and left ventricular performance. Administration of EHNA/NBMPR did not alter physiologic levels of adenine nucleotides (ATP, ADP, AMP), nucleosides (adenosine, inosine), or oxypurines (hypoxanthine, xanthine) before ischemia. The first 10 minutes of normothermic global ischemia resulted in slight depletion of myocardial ATP from 24.67 _+ 2.0 to 20.59 _+ 1.8 nmol/mg protein in the control group (16.54% reduction) and from 25.16 + 2.5 to 21.73 + 1.4 nmol/mg protein in the drug-treated group (13.63% reduction) ( Fig. 3) . Myocardial ATP levels de- . No significant recovery of myocardial ATP values was observed within 10 minutes of reperfusion in either group, except after the third reperfusion period. Statistical analysis revealed that both groups behaved similarly with respect to the time of the experiment (p ---NS,* ANOVA). No further decline in myocardial ATP values was noted in either group after the third episode of ischemia and reperfusion or after 60 minutes of sustained reperfusion. A slight increase in myocardial ATP values was observed at the end of 60 minutes of rcperfusion in the drugtreated group. A transient increase in levels of myocardial ADP and AMP was observed after the first episode of ischemia, and these levels decreased during the first episode of reperfusion (p = NS between groups). Total adenine nucleotide levels followed the pattern of ATP depletion. The adenine nucleotide pool declined rapidly after the first episode of ischemia and then stabilized without further loss after the third episode of ischemia and reperfusion.
Administration of EHNA/NBMPR did not elevate the leve, ls of adenosine or inosine in normal *NS = Not significant. myocardium before ischemia (Tables I and II ). In the intermittent ischemia experiments, adenosine levels increased during 10 minutes of warm ischemia in the EHNA/NBMPR group from 0 to 5.23 + 0.68 nmol/mg protein. Adenosine levels were significantly lower in the control group (0.31 _+ 0.1 nmol/mg protein) than those in the drug-treated group (p < 0.05). After the first episode of reperfusion, adenosine was not detectable in the control group, whereas significant levels of adenosine (2.8 + 0.27 nmol/mg protein) were detected in the drugtreated group. At the end of the first 10 minutes of ischemia, inosine accumulated in the untreated control group (1.60 _+ 0.2 nmol/mg protein) (p < 0.05 versus preischemia) and washed out during reperfusion (Table II) . Inosine levels were 1.03 _+ 0.6 nmol/mg protein in the drug-treated group at the end of the second episode of ischemia. During the second and third episodes of ischemia, accumulation of inosine and adenosine decreased in the control and EHNA/NBMPR groups, respectively. There was no further production of inosine in the control group after the second episode of ischemia. On the other hand, diminishing levels of adenosine were noted in the drug-treated group with subsequent ischemic and reperfusion episodes. Before ischemia, myocardial hypoxanthine and xanthine were undetectable. However, a transient rise in myocardial hypoxanthine and xanthine levels was observed in both groups during the first episode of ischemia and these washed out during reperfusion. The levels of oxypurines, generated during ischemia, compared with the amounts of adenosine and inosine, were negligible. There was no significant loss of myocardial oxidized nicotinamide-adenine dinucleotide observed during warm intermittent global ischemia and reperfusion as compared with preischemic levels.
In the control group, 10 minutes of ischemia resulted in significant ventricular dysfunction (myocardial stunning) in both groups (Fig. 3) . The slope of stroke work/end-diastolic length recovered only to 65% of normal in both groups (p < 0.05 versus preischemia). Subsequent episodes of ischemia and reperfusion did not cause cumulative ventricular dysfunction in the control group or in the drugtreated group. During sustained reperfusion after six episodes of ischemia and reperfusion, left ventricular function was not improved or worsened in the control group after the first episode of ischemia. Administration of EHNA/NBMPR did not change the slope of stroke work/end-diastolic length in normal hearts before ischemia. Five subsequent episodes of ischemia and reperfusion also did not cause additional stunning over that induced by the first ischemic episode in the drug-treated group. There were no significant differences between groups, after each episode of intermittent ischemia and reperfusion, with respect to global ventricular function (p --NS). However, a marked recovery of left ventricular performance (95.1 _+ 11.8 dynes/cm 2 × 103) was observed in the EHNA/NBMPR-treated group during sustained reperfusion (p < 0.05 versus control group, p = NS versus preischemia). Full recovery of left ventricular function was observed at 30 and 60 minutes of sustained reperfusion in the drug-treated group (p < 0.05 versus control group, p = NS versus preischemic function).
The prevalence of reperfusion-mediated ventricular fibrillation observed after the first episode of ischemia was more pronounced in the control group than in the drug-treated group. In the control group, seven out of eight dogs had reperfusion-mediated ventricular fibrillation (87.4%), whereas three out of eight dog hearts fibrillated in the drug-treated group (37.4%) (p < 0.05). Frequency of ventricular tachycardia was also greater (51%) in the control group than in the EHNA/NBMPR-treated group (13%) (p < 0.05). Ventricular arrhythmias did not recur during subsequent episodes of ischemia and reperfusion in either group.
Discussion
The rationale of the present study was to determine whether intermittent warm aortic crosselamping induces cumulative myocardial stunning or whether the myocardium becomes preconditioned after the first episode of ischemia. To achieve this goal, left ventricular performance was correlated with the myocardial level of adenine nucleotides pool intermediates before and after intermittent or sustained myocardial ischemia and reperfusion in a dog model in vivo. The role of ATP catabolism and subsequent release of purines on reperfusion-mediated postischemic ventricular dysfunction and arrhythmias was assessed with the use of selective inhibitors of nucleoside transport (NBMPR) and adenosine deaminase (EHNA).
In the present studies, 60 minutes of sustained warm ischemia and reperfusion resulted in severe loss of ATP (80%), reperfusion-mediated ventricular fibrillation, and severe ventricular dysfunction in the untreated control animals. In the EHNA/ NBMPR-treated group, a marked recovery of ventricular function was observed despite significant depletion of ATP (80%) and concomitant accumulation of adenosine. In the intermittent ischemia model, the first episode of brief ischemia resulted in ATP depletion, ventricular fibrillation, and ventricular dysfunction (stunning) in both the control and drug-treated groups. Five additional episodes of ischemia did not cause cumulative ATP depletion, ventricular fibrillation, or stunning. This is an important observation because of its clinical ramifications. In the clinical setting of cardiac operation, warm intermittent aortic crossclamping was used for coronary artery bypass grafting before the introduction of hypothermia and cardioptegia. This technique is still being used by a limited number of surgeons with satisfactory morbidity and mortality results. Patients undergoing intermittent warm aortic crossclamping may have myocardial stunning after the first ischemic episode and, in the meantime, this may induce an adaptive response to the first episode of oxidative stress similar to that seen in the present study.
Nucleoside trapping by EHNA/NBMPR improved ventricular functional recovery during sustained reperfusion periods in models of both sustained and intermittent ischemia. Left ventricular function remained depressed (stunned) to the same degree as that induced by the first episode of ischemia after 60 minutes of reperfusion in the control group. These results suggest that the stunned heart is able to recover within 30 minutes of sustained reperfusion when pretreated with EHNA/ NBMPR. Because functional recovery was measured at 30-minute intervals during reperfusion after 60 minutes of sustained ischemia, it is not known whether left ventricular function was fully recovered after 10 minutes of reperfusion. Previous studies demonstrated that pharmacologic intervention with EHNA/NBMPR before or after ischemia selectively targets postischemic reperfusion injury without attenuating metabolic derangement during ischemia. [18] [19] [20] [21] Although all animals in the present studies were subjected to 60 minutes of cumulative ischemic time, the pathophysiologic processes in the two experimental protocols might not necessarily be comparable. However, it is interesting to note that significant attenuation of cumulative ventricular dysfunction and arrhythmias occurred during intermittent aortic crossclamping in the presence or absence of inhibitors of nucleoside transport and adenosine deaminase. The mechanisms by which the heart can tolerate intermittent ischemia and reperfusion, after the first ischemic episode, are not known. However, it is well established that myocardial injury sustained by the heart during postischemic reperfusion is directly related to the duration of ischemia and myocardial salvage on reperfusion. Therefore the element of reperfusion may explain the lack of cumulative ATP derangement and vcntricular dysfunction in the present study. Another possible explanation is that the first ischemic episode could have preconditioned the myocardium against additional episodes of ischemia and reperfusion in a manner similar to that previously described by lintiting the infarct size. 12' 16, 17 It is plausible that the "memory" of prior oxidative stress induced certain biochemical changes that made the heart more tolerant to five additional episodes of ischemia. Murry, Jennings, and Reimer 11 showed that the rate of ATP depletion was significantly reduced during repetitive coronary artery occlusion and markedly limited the size of infarction when these hearts were further subjected to a sublethal episode of sustained coronary occlusion in dogs. In the latter study, ventricular function was not measured. It has been reported that activation of A~ receptor, protein kinase C and KAT P channels, and induction of heat shock proteins may play a role in reducing the size of myocardial infarction. 3°-33 It is interesting to note that these interventions are also known to reduce the rate of ATP depletion during prolonged ischemia. Warner and associates 34 hypothesized that preconditioned myocar-dium produces fewer hydrogen ions during sustained ischemia, thus protecting the heart against further injury.
Results from the present studies demonstrate that the ATP pool is better preserved in the model of intermittent ischemia and reperfusion than in the model of sustained ischemia. The latter adaptive response is known to be species independent. Whether this adaptive response to the first episode of ischemia in this model of intermittent global ischemia and reperfusion, that is, lack of cumulative ventricular stunning, could be referred to as a form of preconditioning, is debatable. Nucleoside trapping, during 30 minutes of a sustained ischemic period in dogs, resulted in complete recovery of ventricular function and repletion of ATP. is These results further support previous observations that the release of ATP catabolites, but not ATP levels, plays a crucial role in the phenomena of postischemic ventricular dysfunction "stunning" and vcntricular arrhythmias. ~s' 20 Van der Heide, Reimer, and Jennings 3s reported that intracoronary infusion of adenosine or an adenosine receptor agonist reduces the rate of ATP depletion during lethal episodes of ischemia.
Free radicals have been implicated in myocardial stunning after coronary artery occlusion in the absence of myocardial necrosis. 14 ' 19, 36, 37 Previous work from this laboratory demonstrated that sitespecific blockade of nucleoside transport only at the time of reperfusion attenuated global myocardial stunning in the absence of adenosine. 2~' 36, 38 These results also suggest that free radical generation via the ATP catabolism pathway plays a role in myocardial stunning. Zuoghaib and associates 37 demonstrated that intracoronary infusion of EHNA/ NBMPR augmented adenosine levels during ischemia and attenuated ventricular dysfunction independent of coronary collateral and hemodynamic changes. Changes in the sensitivity of myofilaments to calcium may also contribute to contractile dysfunction. 39 It is not known whether calcium-mediated ventricular dysfunction is a secondary event to free radical-mediated membrane injury.
Whether myocardial stunning is a prerequisite for ischemic preconditioning in the present study may be surmised by the lower recovery (71% of baseline values) of preconditioned myocardium in the untreated control group compared with 23% recovery after 60 minutes of sustained ischemia. Therefore the greater recovery of cardiac function after intermittent ischemia and reperfusion in the untreated control group may reflect an adaptive response to the first short episode of ischemia. Although these results support previous reports that preconditioning does not attenuate myocardial stunning, 4°'4a lack of cumulative ventricular dysfunction in the present study may be partially explained by an ischemic preconditioning phenomenon. Although several pieces of evidence have accumulated that argue against the notion that myocardial stunning induces the phenomenon of ischemic preconditioning, the relationship between stunning and preconditioning remains controversial. [42] [43] [44] [45] [46] The argument is based on the following observations: (1) myocardial stunning persists for hours, whereas the preconditioning protective effect lasts 1 hour or 24 hours;
(2) heat shock, Al-receptor agonists, and KAT P channel openers limit the infarct size, thus mimicking ischemic preconditioning, without the need for a brief ischemic episode 36' 37; and (3) inotropic stimulation by catecholamine increases ventricular contractitity of the stunned myocardium. 45 The latter observations may imply that myocardial stunning is not a prerequisite for ischemic preconditioning. 46 A temporary increase in contractility of the stunned heart induced by infusion of catecholamine, 45 cAMP, or calcium may reflect an adequate contractile reserve of the stunned heart but not necessarily abolish stunning. The heart eventually returns to its stunned state after catecholamine withdrawal. Therefore, by definition, ischemic preconditioning requires a period of ischemia, whereas heat shock, A 1 agonist, and KAa-P channel openers may induce intrinsic mechanisms of protection similar to those of preconditioning but not mediated by ischemia. Most of these interventions are believed to preserve ATP during sustained ischemia. It has been reported that brief episodes (2.5 or 5 minutes) of ischemia and reperfusion before 15 minutes of left anterior descending artery occlusion and 2 hours of reperfusion were not associated with greater recovery of regional contractility. 4° Brief ischemia (5 to 10 minutes) or low-flow ischemia, before cardioplegic arrest at 34 ° C, did not improve left ventricular developed pressure in isolated perfused rabbit hearts. 41 Gall and colleagues 47 demonstrated that although repetitive coronary artery occlusion does not result in cumulative ischemic dysfunction, prior ischemic events significantly alter recovery of postischemic reperfusion. In the latter study, repetitive regional left anterior descending artery occlusion and reperfusion delayed recovery of myocardial creep but not recovery of systolic func-tion. Bolli and associates 48 demonstrated that better regional contractility, as measured by recovery of wall thickening, was associated with a few episodes of left anterior descending artery occlusion but did not continue after 10 occlusions. In the present study, lack of cumulative left ventricular dysfunction and ventricular fibrillation after brief ischemia (10 minutes) suggests that the myocardium became tolerant to additional repetitive global ischemia (preconditioning). Therefore one should not anticipate greater recovery of function or attenuation of myocardial stunning after the first episode of ischemia, but the beneficial effects of brief ischemia and reperfusion are expressed by the limitation of further deterioration of left ventricular function with additional episodes of ischemia (preconditioning).
In the present study, nucleoside trapping accelerated functional recovery of the stunned myocardium when dogs were treated with EHNA/NBMPR. This drug intervention has been shown to attenuate reperfusion-mediated injury by preventing generation of purine-mediated free radical production and subsequent vascular stunning. Failure to achieve a greater recovery of function 4°-46 could be related to persistent vascular damage as a result of injury sustained by the heart during brief ischemia and reperfusion. Stahl, Aversano, and Becker 49 demonstrated that selective enhancement of function of the stunned myocardium was observed by increasing coronary flow. In that study, one would expect that augmentation of contractility would be abolished when the coronary flow returned to the level of that in the stunned heart. Therefore greater recovery of left ventricular performance in the EHNA/NBMPR group, in the present study, may be related to attenuation of reperfusion injury-mediated vascular injury in addition to that induced by ischemic preconditioning.
Chen and associates 5° reported hemodynamic recovery after four 15-minute episodes of intermittent crossclamping in the presence or absence of lidoflazine in dogs. The mechanisms by which lidoflazine, as a nucleoside transport inhibitor, allowed continuous release of adenosine is not known. Myocardial protection by lidoflazine was attributed to endogenous adenosine cardioprotective effects. Results from the same laboratory have demonstrated failure of R75231, a more selective inhibitor than lidoflazine, to improve ventricular function, despite significant accumulation of endogenous adenosine after four 15-minute episodes of intermittent ischemia and reperfusion. 51 Selective blockade of nucleoside transport by NBMPR and EHNA attenuated myocardial stunning after a short period of reperfusion. 1s-21 ' 36-38 The mechanisms of cardioprotective action of EHNA/NBMPR are believed to be related to sitespecific entrapment of nucleosides. ATP repletion after 30 minutes of global ischemia and reperfusion ~s suggests that EHNA/NBMPR-trapped nucleosides are most likely to be compartmentalized inside cells. Indeed, Walsh and colleagues 52 demonstrated that EHNA/NBMPR significantly reduced adenosine release from anoxic rabbit hearts, suggesting that adenosine is trapped in an intracellular compartment. Preservation of ATP seems to play a major role in myocardial preconditioning, as previously proposed. 9-11'3s The mechanism by which ATP is spared, although crucial, is not known. Other cardioprotective mechanisms of preconditioning have been investigated, including A s and A 3 receptor activation, KATe channels, and heat-shock proreins, ls-17 Whether enhanced ventricular functional recovery, after documented myocardial stunning by pretreatment with EHNA/NBMPR, is related to entrapment of endogenous adenosine is not clear from the present study. However, it is well established that adenosine limits the infarct size after prolonged ischemia and reperfusion 3° in a manner similar to that induced by ischemic preconditioning. Adenosine also activates A 1 receptor and NAT P channels. Although infusion of exogenous adenosine can mimic ischemic preconditioning, it failed to increase myocardial tolerance in terms of improvement of left ventricular developed pressure in isolated perfused rat hearts. 53 Therefore the definition of ischemic preconditioning may need to be broadened to include adaptive responses (memory) induced by prior stressfial experiences such as heat shock, beta receptor stimulation, anoxia, alcohol, aspirin, and anesthesia. It is plausible that lack of cumulative stunning is evidence of myocardial preconditioning.
It is concluded that one brief episode of 10 minutes of normothermic global ischemia and reperfusion caused myocardial stunning but augmented myocardial tolerance (that is, preventing cumulative stunning) when hearts were subjected to five subsequent episodes of ischemia and reperfusion. Selective nucleoside trapping may play a crucial role in :myocardial protection against reperfusion-mediated injury and arrhythmias in these models of global ischemia and reperfusion. An understanding of the mechanisms by which ATP is spared during subsequent episodes of ischemia is important and deserves further investigation.
